The Medical Affairs Leaders Forum continues to be the must-attend event for Medical Affairs professionals globally, to develop actionable insights in this increasingly important area. With an entirely new industry speaker lineup for the USA, the 2017 US Edition provides plenty of reasons for clients to come back or first-time attendees to experience the exceptional opportunities to benchmark and network with thought-leaders and industry experts.

Download agenda here for complete speaker list

Pharma & Biotech Industry Experts:


VP & Head of Medical for Europe
Amgen

Vice President, North America Medical Lead, Rare Disease
Pfizer

Rare Disease Patient Engagement and Advocacy Team Leader
Pfizer

Assistant General Counsel, Patient Health and Impact
Pfizer

Senior Medical Director I Global Medical Affairs Lead, Women’s Health
Pfizer

VP & Head, Medical Affairs NA, Rare Diseases
Sanofi Genzyme

Global Senior Director of Medical and Scientific Communications,
Santen

Director, Scientific Communications, and Publications, Established Products and Emerging Markets
Sanofi

Senior Director, Medical Affairs
Sunovion Pharmaceuticals

CEO / Chairman of the Board
Medical Science Liaison Society

Director, Medical Science
Valeant

Medical Director, Medical Science Liaison Team
Pacira Pharmaceuticals

Worldwide Medical Director
Bristol-Myers Squibb​

Lead, US Medical - Hemophilia A & B
Shire

Global Head, Real World Informatics Capabilities and Alliances,
Astellas Pharma

Senior Director, Medical Affairs – Orthopaedics
Ferring Pharmaceuticals

Executive Director,
PFMD 

Vice-President Global Medical Affairs
Amicus Therapeutics, Inc.

Vice President, Global Patient Centered Outcomes and Solutions,
Sanofi


MedTech Industry Experts

Sr. Director – Global Medical Affairs | PACE
Medtronic – Neurovascular

Senior Director - Specialty Surgical Solutions,
Integra LifeSciences

Senior Global Marketing Director & Therapy Segment Leader
Medtronic

Medical Science Manager
Abbott Vascular

WW VP, Medical Affairs, PAS
BD Life Sciences

Medical Director, Clinical Studies Manager, Regulatory Affairs Manager
Thermo Fisher Scientific

Associate Director, Clinical Program Manager,
Avid Radiopharmaceuticals


Patient Organizations

CEO,
National Health Council 

Founder and CEO,
Lyfebulb

Co-founder & CEO,
Antidote

Co-Founder, President,
PatientsLikeMe

Senior Vice President,
National Kidney Foundation 


External Stakeholders

Chief Medical Officer & Director Healthcare Transformation
IBM Healthcare and Life Sciences

Director of Research & Research Associate Professor
Tufts Center for the Study of Drug Development

Director of Pharmacy Strategy and Clinical Integration
Horizon Blue Cross Blue Shield of New Jersey

President
HealthCore 

Vice Chair for Clinical Pathology and Quality, Department of Pathology
Brigham and Women's Hospital and Dana Farber Cancer Institute,
Associate Professor of Pathology
Harvard Medical School

Director of Health Economics
Institute for Clinical and Economic Review (ICER)


Experienced Solution Providers

Vice President -Global Medical Strategy
Veeva

Senior Director, Medical Content Strategy
Veeva

Principal & Owner
Innovative Strategic Communications

Download agenda here for complete speaker list

Here’s what your industry peers are saying about it!

“NextLevel Pharma’s Medical Affairs meeting had two values for me: firstly, it allowed me to share best practices and try to learn what other companies are doing, which is great. Secondly, it was a fantastic networking opportunity, a lot of my peers are here which makes it special. I enjoyed the networking dinner as well, it was a nice walk, beautiful location and a very relaxed and casual atmosphere, NextLevel kept people communicating all the time – it was a fun night!”
Senior Director Medical Affairs Effectiveness, EMEA, Celgene


“I found this Medical Affairs meeting very interesting and beneficial, as I had the opportunity to take part in discussion of the important topics from different perspectives. I believe it was a great chance to meet other professionals and hear their presentations, which I think were very helpful.”
Global Medical Affairs Head, Chiesi Farmaceutici

“I really enjoyed the Medical Affairs Leaders Forum Congress in London. It offered an array of great speakers presenting on very relevant topics. I was able to gather important insights on Medical Affairs value and
practical advice to bring back to my organization and use immediately. This meeting provided a variety of examples of organizational structure as well as sound recommendations on the scope of Medical Affairs.”

Senior Director, Global Medical Science Liaison, Philips Healthcare


“This experience was amazing, and its been for me a moment of great value to enhance myself and to relate with leading professionals in a global contest. I’m surely going home with an increased human and
professional insight This is certainly the best event I could attend.”

Medical Science Liaison, Diabetes, Sanofi

“A thoughtfully organised event with a strong focus on the future direction and role of medical affairs in the pharmaceutical industry”
Medical Science Liaison, Norgine

“A value-added event with highly capable and inspiring speakers. I gathered many insights that will help my company to take the Medical Affairs function to the next level, and met some great new people in the networking sessions. All this was achieved in a friendly and inclusive atmosphere.”
Global Medical Affairs Director, Nutricia

“Thank you so much for making it possible to attend this wonderful and fantastic event in Berlin. It was a very nice experience for myself, and for sure I have found it very beneficial for my current and future
business.”

Medical Manager & Oncology Clinical Research, Astrazeneca, Colombia

This session focuses on Strategic Medical Affairs Management, specifically how Medical Affairs as a function can be at the forefront of offering added-value to key external and internal stakeholders. Furthermore, how Medical Affairs can become a strategic enabler for the entire organization by facilitating strong evidence and engagement that creates clear ROI. The issue of Patient-Centricity in practice will also be examined with perspectives, approaches and case studies presented. This will provide participants with actionable insights to help implement more patient-beneficial and focused activities that put the patient at the center of everything we do.

Speaker List - Day 1

VP & Head of Medical for Europe,
Amgen

CEO,
National Health Council 

Executive Director,
PFMD 

Senior Vice President,
National Kidney Foundation 

Vice President, Global Patient Centered Outcomes and Solutions,
Sanofi

Vice President, North America Medical Lead, Rare Disease,
Pfizer

Rare Disease Patient Engagement and Advocacy Team Leader,
Pfizer

Assistant General Counsel, Patient Health and Impact
Pfizer

Chief Medical Officer & Director Healthcare Transformation
IBM Healthcare and Life Sciences

Senior Medical Director I Global Medical Affairs Lead, Women’s Health,
Pfizer

Vice-President Global Medical Affairs
Amicus Therapeutics, Inc.

Director,
Innovative Scientific Communications

Co-Founder, President
PatientsLikeMe

Founder and CEO,
Lyfebulb

Co-founder & CEO,
Antidote

Director of Pharmacy Strategy and Clinical Integration
Horizon Blue Cross Blue Shield of New Jersey

Vice Chair for Clinical Pathology and Quality, Department of Pathology
Brigham and Women's Hospital and Dana Farber Cancer Institute,
Associate Professor of Pathology
Harvard Medical School

Medical Affairs and MSL teams are increasingly looking to implement next generation medical communication practices. They need to offer essential evidence-based information to stakeholders on demand, through a variety of classical, yet also increasingly digital channels. This stream will focus on three key aspects of medical communication. Firstly, issues such as: protocol writing for internal late-phase studies and research initiatives; working with External Experts (KOLs) to enhance publications, abstracts & posters and receiving proposals for investigator-initiated studies. The second section of this day will focus on medical/scientific communications, including the review process, compliance issues, ensuring the claims made by marketing colleagues are justified and appropriately communicated and also effectively localized from global-level to country-level market requirements. The third area is looking at how the MSL can best be at the forefront of communicating the value message and engaging KOLs and other stakeholders.

Speaker List - Stream 1

VP & Head, Medical Affairs NA, Rare Diseases
Sanofi Genzyme

Global Senior Director of Medical and Scientific Communications
Santen

President & Managing Director
Adelphi Communications

Director, Scientific Communications, and Publications, Established Products and Emerging Markets
Sanofi

Vice President -Global Medical Strategy
Veeva

Senior Director, Medical Content Strategy
Veeva

Senior Director, Medical Affairs
Sunovion Pharmaceuticals

CEO / Chairman of the Board
Medical Science Liaison Society

Director, Medical Science
Valeant

Medical Director, Medical Science Liaison Team
Pacira Pharmaceuticals

Principal & Owner
Innovative Strategic Communications

Generating real world evidence via observational studies, the use of patient registries or Investigator Initiated Trials (IITs) is one of the fastest growing areas of pharmaceutical R&D. Such post-marketing studies are becoming increasingly important as regulatory agencies demand more long-term data which demonstrates effectiveness from a clinical perspective, yet payers are also demanding evidence of economic value. The Medical Affairs unit plays a decisive role in generating this vital evidence and this stream will present solutions to the challenges companies face in generating high-quality evidence which will enable the communication of a compelling “value” argument to all external stakeholders.

Speaker List - Stream 2

Director of Research & Research Associate Professor
Tufts Center for the Study of Drug Development

Global Head, Real World Informatics Capabilities and Alliances
Astellas Pharma

Director of Health Economics
Institute for Clinical and Economic Review (ICER)

Worldwide Medical Director
Bristol-Myers Squibb​

President
HealthCore 

Lead, US Medical - Hemophilia A & B
Shire

Senior Director, Medical Affairs – Orthopaedics
Ferring Pharmaceuticals 

 

This session focuses on the fast-evolving role of Medical Affairs specifically for MedTech companies and the increasingly important need for this function which facilitates overall corporate performance. The different business model of MedTech vs Pharma, necessitates an adjustment in the way KOLs, external experts & patients are engaged with and communicated to. This highly-popular, 1-day stream is back and with new speakers, will enable the MedTech community to get the most out of their Medical Affairs teams and develop a more patient-centric business model.

Speaker List - Day 3

Sr. Director – Global Medical Affairs | PACE
Medtronic – Neurovascular

Medical Science Manager
Abbott Vascular

WW VP, Medical Affairs, PAS
BD Life Sciences

Sr. Global Manager, Physician Relations, Office of Medical Affairs,Peripheral Vascular
Medtronic

Medical Director, Clinical Studies Manager, Regulatory Affairs Manager
Thermo Fisher Scientific

Senior Director - Specialty Surgical Solutions​,
Integra LifeSciences

Associate Director, Clinical Program Manager,
Avid Radiopharmaceuticals

 

This event will provide all delegates the chance to meet one another through our many networking opportunities. With pre-event, mid-morning and mid-afternoon breaks as a standard, this event will also feature a complimentary networking dinner for all participants.

This evening will allow you to meet with our expert speaker panel who represent many stakeholder groups in a less formal setting. Our networking lunches will also allow you plenty of time to meet with your peers and colleagues whilst you refuel through the event.

Event Partners

This event is accredited for CPD (Continuing Professional Development) status

Share with Colleagues